claudine isaacs, sabcs 2022: cemiplimab plus regn3767 in her2- breast cancer: the i-spy2 trial
Published 1 year ago • 69 plays • Length 11:12Download video MP4
Download video MP3
Similar videos
-
14:18
dr. claudine isaacs | san antonio breast cancer symposium 2022 (1) | general session
-
15:55
dr. claudine isaacs | san antonio breast cancer symposium 2022 (2) | general session
-
1:06
sabcs 2022 highlights
-
1:25
sabcs 2022: clinical trial highlights
-
1:51:16
dr. bora lim | challenging types of breast cancer | sabcs 2022 | education session
-
0:55
key highlights from sabcs 2022
-
37:30
advances in breast cancer care with claudine isaacs, md
-
56:01
dr. rinath jeselsohn | demystifying cdks in breast cancer beyond cdk46 | sabcs 2022
-
29:57
dr. prudence francis | premenopausal er breast cancer: past, present, future | sabcs 2022
-
1:00
highlights from the san antonio breast cancer symposium 2022
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
0:56
the san antonio breast cancer symposium (sabcs) 2022
-
2:57
key data from the san antonio breast cancer symposium (sabcs) 2022
-
2:56
key clinical trials in breast cancer presented at sabcs 2021
-
1:40
shayne’s breast cancer story
-
49:56
breast cancer
-
31:24
breast cancer & genetic testing: ask dr. claudine isaacs